The stability of silver nanoparticles in a model of pulmonary surfactant
about
Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epitheliumInhalation of silver nanomaterials--seeing the risksStatic and Dynamic Microscopy of the Chemical Stability and Aggregation State of Silver Nanowires in Components of Murine Pulmonary SurfactantLow-dose AgNPs reduce lung mechanical function and innate immune defense in the absence of cellular toxicityInfluence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lungCardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped NanosilverParticle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticlesPulmonary Toxicity of Instilled Silver Nanoparticles: Influence of Size, Coating and Rat StrainInactivation, Clearance, and Functional Effects of Lung-Instilled Short and Long Silver Nanowires in RatsModeling in vitro cellular responses to silver nanoparticles.Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilver.Avoiding artefacts during electron microscopy of silver nanomaterials exposed to biological environments.Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification.Comparison of 20 nm silver nanoparticles synthesized with and without a gold core: Structure, dissolution in cell culture media, and biological impact on macrophages.Modeling In Vivo Interactions of Engineered Nanoparticles in the Pulmonary Alveolar Lining Fluid.Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.General and programmable synthesis of hybrid liposome/metal nanoparticles.High-resolution analytical electron microscopy reveals cell culture media-induced changes to the chemistry of silver nanowires.Surface coating affects behavior of metallic nanoparticles in a biological environment.Simple in vitro models can predict pulmonary toxicity of silver nanoparticles.Influence of Nanotoxicity on Human Health and Environment: The Alternative Strategies.Algorithm-driven high-throughput screening of colloidal nanoparticles under simulated physiological and therapeutic conditions.A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics.Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H2S-synthesizing enzymes.The acute toxic effects of silver nanoparticles on myocardial transmembrane potential, INa and IK1 channels and heart rhythm in mice.Supported pulmonary surfactant bilayers on silica nanoparticles: formulation, stability and impact on lung epithelial cells.Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study.Exposure to Silver Nanospheres Leads to Altered Respiratory Mechanics and Delayed Immune Response in an in Vivo Murine Model.The Toxic Truth About Carbon Nanotubes in Water Purification: a Perspective View.
P2860
Q28383130-8CC0F5B2-289E-4351-9F30-E6A20475F671Q28385452-BD3047CA-6171-4F33-B0ED-2DD057895AE2Q28389007-334E0B38-77E2-437B-BA4E-3E31B6007EA7Q28389887-5DF9685A-5E38-4D8F-80B4-B45D5EF768F7Q28390486-4B8E7E80-E11D-470F-A35A-CDB8FEEEF6DFQ29248143-3CD2E23A-D10C-468D-884B-52F8E193BC98Q29248667-1E5D7FD1-FD8C-48C7-B8F1-971871CDF296Q29248671-214200FC-F6DC-4AF3-9176-F49DEDBC15FBQ30843272-7DF1082C-0405-4321-A21B-9A5046147E6BQ34390775-1FA94AFF-BF0D-4CDF-B5A3-CABE00807781Q34972497-21853C17-18B6-4684-99AE-1CACEEBCE72EQ35545968-FDAD6352-6955-401D-9FC4-96E5E7BCE174Q35844923-E6082EF8-EF35-46B6-872F-6E8A57E5DFB0Q35862914-095D78A0-0603-435C-A1ED-D2F43938EB27Q35906427-9528A25E-BADE-49AC-9F82-590794809798Q36612289-D3819BD6-881E-49B8-8CA1-940FCDE5F354Q37510209-BB632583-74B4-46B1-948B-2A8414F8347BQ37706761-A44E978D-B4B3-41F1-8D56-5B9BCFE2A303Q38781865-64AD69DB-63F7-4247-98BB-49FA67A923BAQ38799484-4F2804AD-2D09-412C-BD5E-B67CD87D4EBFQ38813548-E8FE4C31-06FC-4A9C-88A5-BE8DD4DD1CE6Q38996201-7E40FA85-0314-4D81-9A7E-1089F64D5B6FQ40262337-3F426C58-E281-468B-B190-71CAC654244CQ41844051-8F02E445-C34C-4100-8352-C9C143F598C2Q46317831-29C04B4B-F054-4E4B-A7B5-0B499F7FD504Q47760741-8D4DC40F-2E69-4D70-AC3D-4588ED576C15Q53608062-30C720E6-1C2B-4AF2-952E-2D23F4022DDEQ53697030-D90D800F-5B79-4937-8DE0-2920EA4FDE8CQ55479748-513F7EA6-D93F-42CF-A7D5-ADC4C7044170
P2860
The stability of silver nanoparticles in a model of pulmonary surfactant
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The stability of silver nanoparticles in a model of pulmonary surfactant
@ast
The stability of silver nanoparticles in a model of pulmonary surfactant
@en
The stability of silver nanoparticles in a model of pulmonary surfactant
@nl
type
label
The stability of silver nanoparticles in a model of pulmonary surfactant
@ast
The stability of silver nanoparticles in a model of pulmonary surfactant
@en
The stability of silver nanoparticles in a model of pulmonary surfactant
@nl
prefLabel
The stability of silver nanoparticles in a model of pulmonary surfactant
@ast
The stability of silver nanoparticles in a model of pulmonary surfactant
@en
The stability of silver nanoparticles in a model of pulmonary surfactant
@nl
P2093
P2860
P50
P356
P1476
The stability of silver nanoparticles in a model of pulmonary surfactant
@en
P2093
Alexandra E Porter
Bey Fen Leo
David S McPhail
Iain E Dunlop
Junfeng Zhang
Milo S Shaffer
Stephan Schwander
Teresa D Tetley
Yoshihiko Kyo
P2860
P304
P356
10.1021/ES403377P
P407
P577
2013-10-01T00:00:00Z